# Filana Therapeutics (FLNA) — News

FLNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/flna/news

## Recent headlines

- [Trading halted: (Flynx) Due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-flynx-due-limit-limit-trading-pause-2610) — AInvest Wire, Oct 13, 2026
- [Alzheimer stocks rose in after-hours trading, with FLNA up 1.3%.](https://www.ainvest.com/news/alzheimer-stocks-rose-hours-trading-flna-1-3-2610-22) — AInvest Wire, Oct 9, 2026
  Alzheimer-related stocks experienced a rise in after-hours trading on Tuesday, with Filana Therapeutics, Inc. Common Stock (FLNA) gaining 1.3%. The increase follows broader market optimism surrounding potential advancements in therapeutic treatments for neurodegenerative diseases. While no recent…
- [Filana Therapeutics shares jump 29% to 95 cents after FDA lifts clinical hold on co's epilepsy drug](https://www.ainvest.com/news/filana-therapeutics-shares-jump-29-95-cents-fda-lifts-clinical-hold-epilepsy-drug-2609) — AInvest Wire, Sep 22, 2026
- [Filana Therapeutics shares jump 35% to $1 premarket after FDA lifts clinical hold on co's epilepsy drug](https://www.ainvest.com/news/filana-therapeutics-shares-jump-35-1-premarket-fda-lifts-clinical-hold-epilepsy-drug-2609) — AInvest Wire, Sep 22, 2026
  Filana Therapeutics Inc. (NASDAQ: FILN) shares surged 35% to $1 in premarket trading on September 22, 2026, following the U.S. Food and Drug Administration’s (FDA) decision to lift a clinical hold on the company’s investigational drug for epilepsy. The FDA had previously placed a hold on the drug’s…
- [Filana Therapeutics: Phase 2A study to enroll 40 subjects at 13 U.S. sites over 16 weeks](https://www.ainvest.com/news/filana-therapeutics-phase-2a-study-enroll-40-subjects-13-sites-16-weeks-2609) — AInvest Wire, Sep 22, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).